107 related articles for article (PubMed ID: 4944951)
1. Pulmonary antibacterial defenses with pure oxygen breathing.
Shurin PA; Permutt S; Riley RL; Radford EP
Proc Soc Exp Biol Med; 1971 Sep; 137(4):1202-8. PubMed ID: 4944951
[No Abstract] [Full Text] [Related]
2. In Vivo Pharmacodynamic Target Assessment of Delafloxacin against Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae in a Murine Lung Infection Model.
Lepak AJ; Andes DR
Antimicrob Agents Chemother; 2016 Aug; 60(8):4764-9. PubMed ID: 27216072
[TBL] [Abstract][Full Text] [Related]
3. [Experimental study of aeorsol elemorphocycline].
Lagert IK; Poliak MS
Antibiotiki; 1970 Jun; 15(6):554-7. PubMed ID: 5460172
[No Abstract] [Full Text] [Related]
4. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
[TBL] [Abstract][Full Text] [Related]
5. Amoxicillin: microbiological activity in vitro and in vivo (author's transl).
Renzini G; Oliva B; Piccolomini R; Nicoletti M
Antibiotica; 1973; 11(3-4):117-33. PubMed ID: 4619320
[No Abstract] [Full Text] [Related]
6. [Antibacterial activity in vitro and in vivo of the trimethoprim-sulphamethoxazole combination].
Renzini G; Ravagnan G; Bormioli P; D'Alessandro A
Antibiotica; 1969 Dec; 7(4):250-68. PubMed ID: 5004706
[No Abstract] [Full Text] [Related]
7. A silver bullet for colonization and infection with methicillin-resistant Staphylococcus aureus still eludes us.
Rice LB
Clin Infect Dis; 1999 May; 28(5):1067-70. PubMed ID: 10452636
[No Abstract] [Full Text] [Related]
8. Degradable antimicrobial polycarbonates with unexpected activity and selectivity for treating multidrug-resistant Klebsiella pneumoniae lung infection in mice.
Yang C; Lou W; Zhong G; Lee A; Leong J; Chin W; Ding B; Bao C; Tan JPK; Pu Q; Gao S; Xu L; Hsu LY; Wu M; Hedrick JL; Fan W; Yang YY
Acta Biomater; 2019 Aug; 94():268-280. PubMed ID: 31129359
[TBL] [Abstract][Full Text] [Related]
9. Effect of cytostatic agents on the number of alveolar phagocytes and the efficacy of ceftriaxone in an experimental murine lung infection.
Calame W; Mattie H
Eur Respir J; 1991 Mar; 4(3):340-6. PubMed ID: 1864349
[TBL] [Abstract][Full Text] [Related]
10. Does it ever make sense to treat a bacterial infection with a drug against which the responsible pathogen possesses a resistance mechanism?
Tassios PT; Miriagou V
Clin Microbiol Infect; 2011 Aug; 17(8):1126-7. PubMed ID: 21689208
[No Abstract] [Full Text] [Related]
11. Aerosolized vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infection in cystic fibrosis.
Máiz L; Cantón R; Mir N; Baquero F; Escobar H
Pediatr Pulmonol; 1998 Oct; 26(4):287-9. PubMed ID: 9811080
[No Abstract] [Full Text] [Related]
12.
Zhao M; Lepak AJ; Marchillo K; Andes DR
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332063
[TBL] [Abstract][Full Text] [Related]
13. 3-acyloxymethyl-7-(2-thienylacetamido)-3-cephem-4-carboxylic acids. An improved synthesis and biological properties.
Berges DA
J Med Chem; 1975 Dec; 18(12):1264-5. PubMed ID: 811800
[No Abstract] [Full Text] [Related]
14. Treatment of respiratory Klebsiella pneumoniae infection in mice with aerosols of kanamycin.
Berendt RF; Long GG; Walker JS
Antimicrob Agents Chemother; 1975 Nov; 8(5):585-90. PubMed ID: 1108778
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial activity of human neutrophil defensins in experimental infections in mice is accompanied by increased leukocyte accumulation.
Welling MM; Hiemstra PS; van den Barselaar MT; Paulusma-Annema A; Nibbering PH; Pauwels EK; Calame W
J Clin Invest; 1998 Oct; 102(8):1583-90. PubMed ID: 9788972
[TBL] [Abstract][Full Text] [Related]
16. [Correlation of resistance of Staphylococcus aureus and Klebsiella friedlender to monomycin in vitro and in vivo].
Dratvin SA
Antibiotiki; 1966 Jun; 11(6):552-7. PubMed ID: 4871258
[No Abstract] [Full Text] [Related]
17. Effect of etoposide and cyclophosphamide on an experimental pulmonary infection in mice.
Calame W; Mattie H
Agents Actions; 1989 Jan; 26(1-2):77-8. PubMed ID: 2653009
[TBL] [Abstract][Full Text] [Related]
18. Tobramycin therapy of pulmonary infections in patients with cystic fibrosis.
Hawley HB; Lewis RM; Swartz DR; Gump DW
Curr Ther Res Clin Exp; 1974 May; 16(5):414-23. PubMed ID: 4209057
[No Abstract] [Full Text] [Related]
19. Treatment of Staphylococcus aureus infections in mice with oxygen at various pressures and concentrations.
Barnwell P; Sopher S; Fleckinger RR; Rhoden CH; Smith IM
Am Rev Respir Dis; 1966 Nov; 94(5):756-60. PubMed ID: 5925624
[No Abstract] [Full Text] [Related]
20. Therapeutic effects of cefpirome, a new cephalosporin, on various models of infections in mice and rats.
Arai S; Kobayashi S; Hayashi S
Jpn J Antibiot; 1990 Jan; 43(1):1-8. PubMed ID: 2190011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
